{
  "docId": "019de076-3901-734c-833f-b5b0e2d3aa41",
  "docSlug": "e86c5f257c7f518e1f9c16c922f96c7d",
  "documentTitle": "Exscientia | Investor Presentation Deck | 76 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 59,
  "pageCount": 76,
  "prevPage": 58,
  "nextPage": 60,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "Includes a heatmap showing synergy scores across cell lines and two dose-response line charts showing increased inhibition in combination.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-3901-734c-833f-b5b0e2d3aa41/59",
  "deckHref": "/decks/019de076-3901-734c-833f-b5b0e2d3aa41",
  "deckJsonHref": "/decks/019de076-3901-734c-833f-b5b0e2d3aa41.json",
  "deckAnchorHref": "/decks/019de076-3901-734c-833f-b5b0e2d3aa41#slide-59",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.42,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "chart",
      "text": "‘539 combination synergy (calculated using Bliss independence model)",
      "attrs": null,
      "subkind": "heatmap",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3be69762-3a11-415f-a405-297833867937",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.23,
        "x": 0.48,
        "y": 0.35
      },
      "kind": "chart",
      "text": "DMS79 SCLC-A model",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "296dae20-6786-4d9d-866f-34d4fdaedc7a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.23,
        "x": 0.73,
        "y": 0.35
      },
      "kind": "chart",
      "text": "H345 SCLC-A model",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8480bd87-aee1-4f78-b737-6a3924c8ac11",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.84
      },
      "kind": "paragraph",
      "text": "‘539 in combination with SoC has potential in most common SCLC patient sub-types even for those that are not responsive to LSD1i as a single agent",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f695360d-9c78-4c58-86f3-f8236f1926dd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.42,
        "x": 0.04,
        "y": 0.7
      },
      "kind": "table",
      "text": "SCLC molecular subtypes percentage table",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b9f4bec4-0c70-4047-a9f6-a34c80d68267",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.86,
        "x": 0.07,
        "y": 0.13
      },
      "kind": "title",
      "text": "Combinations enhance anti-proliferative effects in ‘539 unresponsive SCLC cell lines",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "84c70f43-843a-4769-b7db-13e0d0658378",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.86,
        "x": 0.07,
        "y": 0.06
      },
      "kind": "title",
      "text": "‘539 synergises with approved SoC and targeted therapies",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8b514331-9d8c-4e4a-a158-33402b144088",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Heatmap matrix",
      "slug": "heatmap-matrix",
      "agent": null,
      "layer": "slide",
      "matchId": "5e9caeaf-a330-4c37-bd2c-e96b8c068e48",
      "evidence": "chart/heatmap: ‘539 combination synergy (calculated using Bliss independence model)",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "Bliss independence model",
      "slug": null,
      "matchId": "6c0c09a5-e692-4480-b4b2-3b7afb2e8799",
      "evidence": "Explicitly mentioned in the heatmap title",
      "confidence": 1
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}